Published in Toxicol Lett on March 28, 2009
TRAIL treatment provokes mutations in surviving cells. Oncogene (2010) 1.21
Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach. Environ Mol Mutagen (2016) 0.78
Refractory status epilepticus, serious rhabdomyolysis, acute liver injury, and pancytopenia after a massive intake of ethyl methanesulfonate: a case report. Int J Clin Exp Med (2015) 0.75
Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals? AIDS (2016) 0.75
Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay. Environ Mol Mutagen (2017) 0.75
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet (2008) 2.77
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens (2007) 1.68
CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity (2005) 1.63
MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol Lett (2009) 1.60
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res (2005) 1.45
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutat Res (2007) 1.22
Polycyclic aromatic hydrocarbons in foods: human exposure through the diet in Catalonia, Spain. J Food Prot (2003) 1.15
Inter- and intraobserver assessment of periacetabular osteodensitometry after cemented and uncemented total hip arthroplasty using computed tomography. Arch Orthop Trauma Surg (2005) 1.11
Contribution of new technologies to characterization and prediction of adverse effects. Crit Rev Toxicol (2015) 1.08
Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels. Am J Pathol (2006) 1.07
Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1. J Exp Med (2005) 1.04
In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutat Res (2009) 1.03
Computational toxicology in drug development. Drug Discov Today (2008) 1.01
Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol Lett (2009) 1.01
Tobacco smoke: unraveling a controversial subject. Exp Toxicol Pathol (2008) 1.00
Helicobacter pylori determination in non-municipal drinking water and epidemiological findings. Isotopes Environ Health Stud (2004) 0.92
Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat Res (2008) 0.92
Towards the creation of an international toxicology information centre. Toxicology (2005) 0.91
Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. J Bone Miner Metab (2008) 0.86
Modelling of patient EMS exposure: translating pharmacokinetics of EMS in vitro and in animals into patients. Toxicol Lett (2009) 0.85
Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety. Toxicol In Vitro (2008) 0.83
Mesenchymal stem cells and carcinoma-associated fibroblasts sensitize breast cancer cells in 3D cultures to kinase inhibitors. Int J Oncol (2011) 0.83
Polychlorinated naphthalenes in foods: estimated dietary intake by the population of Catalonia, Spain. Environ Sci Technol (2003) 0.83
Physical responses of different small-sided game formats in elite youth soccer players. J Strength Cond Res (2012) 0.82
Preclinical perspectives on bisphosphonate renal safety. Oncologist (2005) 0.82
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas. Cancer Chemother Pharmacol (2013) 0.81
Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products. Regul Toxicol Pharmacol (2013) 0.81
The embryonic stem cell test for the early selection of pharmaceutical compounds. ALTEX (2007) 0.80
Strategies in case of positive in vivo results in genotoxicity testing. Mutat Res (2010) 0.80
Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept, Roche): overview. AIDS Res Ther (2009) 0.79
EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations. Toxicol Lett (2009) 0.79
Harmonization of rat fetal external and visceral terminology and classification. Report of the Fourth Workshop on the Terminology in Developmental Toxicology, Berlin, 18-20 April 2002. Reprod Toxicol (2003) 0.79
PX4+, P2X5+, and P5X2+ (X=Br, I) salts of the superweak Al(OR)4- anion [R=C(CF3)3]. Chemistry (2002) 0.78
Human exposure to dioxins through the diet in Catalonia, Spain: carcinogenic and non-carcinogenic risk. Chemosphere (2003) 0.78
The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile mice. Birth Defects Res B Dev Reprod Toxicol (2013) 0.78
The effects of interleukin-6 signal blockade on fertility, embryo-fetal development, and immunization in vivo. Birth Defects Res B Dev Reprod Toxicol (2012) 0.78
Harmonization of description and classification of fetal observations: achievements and problems still unresolved: report of the 7th Workshop on the Terminology in Developmental Toxicology Berlin, 4-6 May 2011. Reprod Toxicol (2012) 0.77
Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat Res (2004) 0.77
Levels of polychlorinated biphenyls in foods from Catalonia, Spain: estimated dietary intake. J Food Prot (2003) 0.77
Embryofetal development study of vismodegib, a hedgehog pathway inhibitor, in rats. Birth Defects Res B Dev Reprod Toxicol (2014) 0.76
Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man. J Mol Endocrinol (2013) 0.76
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regul Toxicol Pharmacol (2013) 0.76
Morphologic and functional effects of gamma secretase inhibition on splenic marginal zone B cells. Int J Alzheimers Dis (2012) 0.75
[Sudden death of a child due to aspiration of the gastric content during an infection with Norwalk-like virus]. Rev Cubana Med Trop (2007) 0.75
Lewis acid stabilized OPI3: implications for the nature of free OPI3. Chemistry (2006) 0.75
[Phytotherapy in geriatrics and gerontology]. Forsch Komplementmed (2014) 0.75